ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AF01 | G | Rivaroxaban - 15mg | 10552 | 73420/1 | RIBAVAN | 15mg | 30 | Tablet, film coated | Oral | Droguerie de l'Union | Algorithm S.A.L. (Packager and final batch releaser), S.C. Labormed-Pharma SA, Romania or Saneca Pharmaceuticals a.s, Slovak Republic (Bulk mamufacturer) | Lebanon | 1,343,843 L.L | 23.08 | B | Algorithm S.A.L. | Lebanon | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AF01 | B | Rivaroxaban - 15mg | 6773 | 97004/12 | XARELTO | 15mg | 28 | Tablet, film coated | Oral | Droguerie R. Pharaon & Fils S.A.L. | Bayer AG | Germany | 4,440,862 L.L | 23.08 | B | Bayer AG | Germany | 2/5/2024 | 0 |
B01AF01 | G | Rivaroxaban - 15mg | 10411 | 140518/1 | RIXALTA 15 | 15mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 1,164,664 L.L | 23.08 | B | 2/5/2024 | 0 | ||
B01AF01 | G | Rivaroxaban - 15mg | 11064 | 6720/1 | VAROXA | 15mg | 30 | Tablet, film coated | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 1,343,843 L.L | 23.08 | A2 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
B01AF01 | G | Rivaroxaban - 15mg | 10359 | 100720/1 | XAVIRAN | 15mg | 30 | Tablet, film coated | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 952,208 L.L | 23.08 | B | 2/5/2024 | 0 | ||
B01AF01 | G | Rivaroxaban - 15mg | 11824 | 152020/1 | ZARLAN | 15mg | 42 | Tablet, film coated | Oral | Sadco | Dar Al Dawa Development & Investment Co Ltd | Jordan | 6,144,048 L.L | 23.08 | B | Dar Al Dawa Development & Investment Co Ltd | Jordan | 2/5/2024 | 0 |
B01AF01 | G | Rivaroxaban - 15mg | 11825 | 151920/1 | ZARLAN | 15mg | 28 | Tablet, film coated | Oral | Sadco | Dar Al Dawa Development & Investment Co Ltd | Jordan | 4,098,720 L.L | 23.08 | B | Dar Al Dawa Development & Investment Co Ltd | Jordan | 2/5/2024 | 0 |